文献速递骨肿瘤小儿骨科

儿童肱骨可延长假体置换术后的长期结果

The long-term results of extendable endoprostheses of the humerus in children after the resection of a bone sarcoma.
PubMed 文献 · Bone Joint J · 2020-01-01

本研究回顾了35例因骨肉瘤切除后接受肱骨可延长假体置换的儿童患者,中位随访10.6年,十年假体存活率为75%,并发症发生率为37%,其中肱骨近端半脱位发生率为54%但仅17%有症状,9岁以下儿童半脱位风险显著更高(86% vs 33%,p=0.002)。结论认为可延长假体是可靠的肱骨重建方法,但低龄儿童需警惕半脱位风险。

要点

  • 儿童肱骨骨肉瘤切除后使用可延长假体,十年假体存活率为75%。
  • 9岁以下儿童肱骨近端半脱位风险显著高于9岁及以上儿童(86% vs 33%,p=0.002)。
  • 无菌性松动是假体失败最常见原因(11%),最终随访时3例肢体短缩≥5 cm。

核心结论

  • 可延长假体置换是儿童肱骨骨肉瘤切除后可靠的重建方法,但9岁以下儿童半脱位风险高。

研究设计与样本

  • 回顾性研究,纳入35例连续接受肱骨可延长假体置换的儿童患者,其中男孩17例、女孩18例,初次手术中位年龄9岁(IQR 7–11)。

主要发现

  • 中位随访10.6年(IQR 3.9–20.4),十年假体存活率为75%。
  • 13例(37%)出现并发症,肱骨近端半脱位19例(54%),其中仅6例(17%)有症状。
  • 9岁以下儿童半脱位发生率86%,9岁及以上为33%(p=0.002)。
  • 假体失败9例(26%),最常见原因为无菌性松动(4例,11%)。
  • 23例(66%)进行了假体延长,最终随访时3例肢体短缩≥5 cm,平均MSTS功能评分为79%(73%–90%)。

关键数值与推荐

  • 9岁以下儿童肱骨近端半脱位发生率86%,显著高于9岁及以上儿童的33%(p=0.002)。
  • 十年假体存活率为75%,假体失败率26%,无菌性松动发生率11%。

临床怎么用

  • 对9岁以下儿童行肱骨可延长假体置换时,应充分评估半脱位风险并加强术后监测。
  • 可延长假体可用于儿童肱骨骨肉瘤切除后的重建,但需告知患者及家属假体失败和肢体短缩的长期风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The purpose of this study was to report the long-term results of extendable endoprostheses of the humerus in children after the resection of a bone sarcoma. METHODS: A total of 35 consecutive patients treated with extendable endoprosthetic replacement of the humerus in children were included. There were 17 boys and 18 girls in the series with a median age at the time of initial surgery of nine years (interquartile range (IQR) 7 to 11). RESULTS: The median follow-up time was 10.6 years (IQR 3.9 to 20.4). The overall implant survival at ten years was 75%. Complications occurred in 13 patients (37%). Subluxation at the proximal humerus occurred in 19 patients (54%) but only six (17%) were symptomatic. Subluxation was seen more commonly in children under the age of nine years (86%) than in those aged nine years or more (33%) (p = 0.002). Implant failure occurred in nine patients (26%): the most common cause was aseptic loosening (four patients, 11%). Lengthening of the implant was carried out in 23 patients (66%). At final follow up, three patients had a limb that was shortened by 5 cm or more. The mean Musculoskeletal Tumor Society (MSTS) functional score was 79% (73% to 90%). CONCLUSION: Extendable endoprosthetic replacement is a reliable method of reconstructing humerus after excision of a bone sarcoma. Children who are less than nine years old have a high risk of subluxation. Cite this article: Bone Joint J 2020;102-B(1):64-71.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Tsuda Y, Fujiwara T, Stevenson JD, et al. The long-term results of extendable endoprostheses of the humerus in children after the resection of a bone sarcoma. Bone Joint J. 2020. PMID: 31888359. doi:10.1302/0301-620X.102B12.BJJ-2020-0124.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。